Guardian Pharmacy Services, Inc. (GRDN) SEC filings

GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30157% above fair value

$49.38−0.60 (-1.20%)

Close on Nov 12, 2026Market cap $3.13BP/E –Yield –

SEC filings

36 of Guardian Pharmacy Services's most recent filings on SEC EDGAR

Document	Form	Period	Filed	Source
Quarterly report	10-Q	Sep 30, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Nov 5, 2026	Nov 5, 2026	SEC EDGAR
Current report	8-K	Sep 10, 2026	Sep 10, 2026	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Aug 6, 2026	Aug 6, 2026	SEC EDGAR
Current report	8-K	Jun 22, 2026	Jun 22, 2026	SEC EDGAR
Current report	8-K	May 21, 2026	May 28, 2026	SEC EDGAR
Current report	8-K	May 5, 2026	May 7, 2026	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2026	May 6, 2026	SEC EDGAR
Current report	8-K	May 6, 2026	May 6, 2026	SEC EDGAR
Proxy statement	DEF 14A	May 5, 2026	Mar 26, 2026	SEC EDGAR
Current report	8-K	Mar 18, 2026	Mar 23, 2026	SEC EDGAR
Annual report	10-K	Dec 31, 2025	Mar 11, 2026	SEC EDGAR
Current report	8-K	Mar 11, 2026	Mar 11, 2026	SEC EDGAR
Current report	8-K	Jan 13, 2026	Jan 13, 2026	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Nov 10, 2025	Nov 10, 2025	SEC EDGAR
Current report	8-K	Oct 14, 2025	Oct 14, 2025	SEC EDGAR
Current report	8-K	Sep 18, 2025	Sep 18, 2025	SEC EDGAR
Quarterly report	10-Q	Jun 30, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Aug 11, 2025	Aug 11, 2025	SEC EDGAR
Current report	8-K	Jun 18, 2025	Jun 18, 2025	SEC EDGAR
Current report	8-K	May 20, 2025	May 20, 2025	SEC EDGAR
Current report	8-K	May 9, 2025	May 12, 2025	SEC EDGAR
Quarterly report	10-Q	Mar 31, 2025	May 12, 2025	SEC EDGAR
Current report	8-K	May 12, 2025	May 12, 2025	SEC EDGAR
Current report	8-K	Mar 24, 2025	Mar 28, 2025	SEC EDGAR
Proxy statement	DEF 14A	May 9, 2025	Mar 28, 2025	SEC EDGAR
Annual report	10-K	Dec 31, 2024	Mar 26, 2025	SEC EDGAR
Current report	8-K	Mar 26, 2025	Mar 26, 2025	SEC EDGAR
Current report	8-K	Mar 3, 2025	Mar 3, 2025	SEC EDGAR
Current report	8-K	Feb 5, 2025	Feb 11, 2025	SEC EDGAR
Current report	8-K	Dec 20, 2024	Dec 20, 2024	SEC EDGAR
Quarterly report	10-Q	Sep 30, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Nov 12, 2024	Nov 12, 2024	SEC EDGAR
Current report	8-K	Sep 25, 2024	Sep 30, 2024	SEC EDGAR

Where these numbers come from

Parsed from the XBRL in Guardian Pharmacy Services's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is GRDN.

Compare: GRDN vs NHC · GRDN vs PETS · GRDN vs YI · GRDN vs LESLQ · GRDN vs OMCL

Revenue growth4.9% · median -0.0%

Gross margin22.4% · median 33.7%

Operating margin6.5% · median -5.7%

Net margin5.1% · median -6.7%

Company	Revenue	Growth
NHC	$1.58B	+5.6%
GRDN	$1.46B	+4.9%
OMCL	$1.24B	+5.6%
LESLQ	$1.18B	-5.7%
PETS	$160.26M	-19.2%
YI	–	–

Company

Next earnings (est.): Mar 10, 2027, during market hours
Exchange: NYSE
Industry: Retail-Drug Stores and Proprietary Stores
Fiscal year ends: December 31
Employees: 3,600
Held by institutions: 46.6%
Auditor: Ernst & Young LLP
SEC CIK: 1802255

Advertisement
300 × 250

See a number that looks wrong?